2006 Feb;20(2):377-9
Regulatory Status None of KLOW Blend's four components BPC-157, GHK-Cu, TB-500, or KPV is approved by the FDA as a drug for any indication
Front Physiol 7:594
3 Its side effects have been classified into two groups: those that cause symptoms only, such as nausea, headaches, lethargy, mucositis, and alopecia, and those that could lead to fatal conditions, such as cytopenia, interstitial lung pathology, or MTX-induced pneumonitis, and hepatic conditions, such as fibrosis and cirrhosis
This allows practitioners to quickly identify patterns of dysfunction across metabolic pathways, organic acid testing supports a functional and integrative approach to patient care, helping individuals better understand their unique biochemistry and optimize their health journey